A putative frameshift variant in the CHM gene is associated with an unexpected splicing alteration in a choroideremia patient.

A careful molecular characterization of the c.1335dup variant's effect explains the relationship between genotype and phenotype severity in a CHM patient and provides new perspectives for the study of therapeutic strategies based on splicing correction in human diseases.